# HSG and Tubal Patency Study

> **NCT02146248** · NA · COMPLETED · sponsor: **Jeffrey Jensen** · enrollment: 11 (actual)

## Conditions studied

- Tubal Patency

## Interventions

- **DRUG:** combined oral contraceptive
- **DRUG:** DepoProvera

## Key facts

- **NCT ID:** NCT02146248
- **Lead sponsor:** Jeffrey Jensen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-01
- **Final completion:** 2015-04
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2017-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02146248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02146248, "HSG and Tubal Patency Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02146248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*